Frequently Asked Questions
The market is segmented based on , By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others), Treatment Type (Non-surgical Treatment, Surgical Treatment), Drugs (Systematic Antibiotics, Local Antibiotics), Route of Administration (Oral, Injectable), End-User (Hospitals, Dental Clinic, Dental Academics and Research Institutes, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) – Industry Trends and Forecast to 2030.
.
The Global Periodontal Disease Treatment Market size was valued at USD 734.80 USD Million in 2022.
The Global Periodontal Disease Treatment Market is projected to grow at a CAGR of 9.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Bausch Health Companies , Colgate,Palmolive Company Limited, Mylan N.V, Lyne Laboratories, WOCKHARDT, Xttrium Laboratories, Sunstar Suisse S.A, 3M, Dexcel Pharma, Izun Pharmaceuticals, Tolmar Pharmaceuticals , Pfizer , Noveome Biotherapeutics , Kaken Pharmaceutical Co.,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
